Sort
50,496 grants matching “lung cancer”
Genetic Epidemiology of Lung Cancer
$982,565Marshall W Anderson · University Of Cincinnati · U01 · FY2009 · CA
Chromatin Remodeling and Gene Activation
$982,543David J Clark · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD
Promoting follow-up of abnormal cancer screening tests using population-basedsystems to support stepped care multilevel intervention
$982,509Jennifer S Haas · Massachusetts General Hospital · U01 · FY2020 · CA
New Paradigms for Targeting Truncal Driver Mutations
$982,500William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2017 · CA
New Paradigms for Targeting Truncal Driver Mutations
$982,500William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2020 · CA
New Paradigms for Targeting Truncal Driver Mutations
$982,500William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2016 · CA
New Paradigms for Targeting Truncal Driver Mutations
$982,500William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2021 · CA
Expanding the Market and Success Rates for Myeloablative Cancer Treatments Using PUL-042, an Innate Immune Stimulant
$982,488Brenton Scott · Pulmotect, Inc · R44 · FY2015 · HL
TASK ORDER TITLE: PREVENTING LUNG ADENOCARCINOMA (LUAD) USING TRAIL INDUCING AGENT, ONC201BASE CONTRACT TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT
$982,258Chinthalapally Rao · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2022 · CA
Development of Natural Product Leads as Anticancer Therapeutics
$981,960John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
2/3: The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)
$981,839Christina Ciecierski · Northeastern Illinois University · U54 · FY2021 · CA
Next Generation Smart Nanoparticles
$981,050Paul Alivisatos · Stanford University · U54 · FY2012 · CA
Nanotechnology for Multiplexed and Intraoperative Cancer Detection
$980,999Shuming Nie · Emory University · RC2 · FY2009 · CA
DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs
$980,918Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$980,906Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
MIT Center for Environmental Health Sciences
$980,566John M Essigmann · Massachusetts Institute Of Technology · P30 · FY2017 · ES
PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm
$980,392John Gillespie · 20/20 Genesystems, Inc. · R44 · FY2012 · CA
CORE CENTER FOR GENE THERAPY
$980,282University Of Washington · P30 · FY2002 · DK
CORE CENTER FOR GENE THERAPY
$980,282University Of Washington · P30 · FY2001 · DK
CORE CENTER FOR GENE THERAPY
$980,282University Of Washington · P30 · FY2003 · DK
CORE CENTER FOR GENE THERAPY
$980,282University Of Washington · P30 · FY2000 · DK
Angiogenesis and Tumor Growth
$980,168Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
UNIVERSITY OF TEXAS SPORE IN LUNG CANCER
$980,000University Of Texas Sw Med Ctr/Dallas · P50 · FY2000 · CA
Missouri Valley Cancer Consortium CCOP
$980,000Missouri Valley Cancer Consortium, Inc. · U10 · FY2002 · CA
Leveraging Diversity in Cancer Epidemiology Cohorts and Novel Methods to Improve Polygenic Risk Scores
$979,999David V Conti · University Of Southern California · U01 · FY2022 · CA